Tang Sydney Cw
Division of Nephrology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong.
Nephrology (Carlton). 2018 Oct;23 Suppl 4:72-75. doi: 10.1111/nep.13468.
Hong Kong experiences a progressive rise in the prevalence of treated end-stage renal disease (ESRD) as recorded by the Hong Kong Renal Registry managed by the Hospital Authority (HA) that takes care of 90 - 95% of the ESRD burden. The CKD burden is envisaged to be high, as reflected by 2 initiatives - SHARE which detected a high prevalence of urine or blood pressure abnormalities among 1,201 asymptomatic individuals who underwent screening, and RISKS that aimed to further characterize the spread of CKD in the asymptomatic population. For CKD prevention, two statutory bodies - the HA and Hong Kong College of Physicians (HKCP), and two non-governmental organizations - Hong Kong Society of Nephrology (HKSN) and Hong Kong Kidney Foundation (HKKF), all have a role to play. The Central Renal Committee (CRC) operated under HA co-produces with HKCP and HKSN a clinical practice guideline for the provision of renal service in Hong Kong which includes CKD care and prevention. HKSN now holds annual educational symposia and a Continuous Medical Education (CME) course in partnership with the HKCP and Asian Pacific Society of Nephrology in addition to its Annual Scientific Meeting. The HKSN also provides a collective International Society of Nephrology (ISN) membership for all its full members to enhance education and other pertinent initiatives. For public education, the HKSN and HKKF participate in the annual World Kidney Day event and organize free blood pressure and CKD surveys in public housing estates to increase public awareness of CKD. The latter is also effected via regular promotion through the mass media.
香港末期肾病（ESRD）的治疗患病率呈逐步上升趋势，这一数据由医院管理局（HA）管理的香港肾脏注册处记录，该注册处承担了90%-95%的ESRD负担。预计慢性肾脏病（CKD）负担也很高，这从两项举措中可见一斑：一项名为SHARE的举措在1201名接受筛查的无症状个体中检测到尿液或血压异常的高患病率；另一项名为RISKS的举措旨在进一步描述CKD在无症状人群中的传播情况。对于CKD的预防，两个法定机构——医院管理局和香港内科医学院（HKCP），以及两个非政府组织——香港肾脏病学会（HKSN）和香港肾脏基金（HKKF），都发挥着作用。在医院管理局运作的中央肾脏委员会（CRC）与香港内科医学院和香港肾脏病学会共同制定了一份香港肾脏服务临床实践指南，其中包括CKD的护理和预防。香港肾脏病学会现在除了举办年度科学会议外，还与香港内科医学院和亚太肾脏病学会合作举办年度教育研讨会和继续医学教育（CME）课程。香港肾脏病学会还为其所有正式会员提供国际肾脏病学会（ISN）的集体会员资格，以加强教育及其他相关举措。在公众教育方面，香港肾脏病学会和香港肾脏基金参与年度世界肾脏日活动，并在公共屋邨组织免费血压和CKD调查，以提高公众对CKD的认识。后者也通过大众媒体的定期宣传来实现。
